GENERIC NAME OF MEDICINAL PRODUCT:

A. Methohexital sodium for Injection, USP (500mg)
B. Methohexital sodium for Injection, USP (2.5g)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Methohexital sodium for Injection, USP (500mg)
Composition:
Each vial contains:
Methohexital sodium..............500mg
Anhydrous Sodium Carbonate.............30mg

B. Methohexital sodium for Injection, USP (2.5g)
Composition:
Each vial contains:
Methohexital sodium..............2.5g
Anhydrous Sodium Carbonate.............150mg


THERAPEUTIC INDICATIONS:

Methohexital, a barbiturate, is used for the induction of anesthesia prior to the use of other general anesthetic agents and for induction of anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli.

DIRECTION OF USE:

Only use bacteriostatic free diluents.

CAUTION & WARNING:

CAUTION: Not to be used if reconstituted solution contains visible particulate matter.
See full prescribing information for additional storage, dosage, route of administration & dilution instruction.
Do not administer without reading directions in full prescribing information.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE
WARNING: Not to be sold by retail without the prescription of a Registered Medical Practitioner only.
Contains sufficient material for several average administration.

STORAGE & DOSAGE:

Storage: Store between 20° to 25°C.
Keep all medicines out of reach of children.
Dosage: As directed by Physician.

Methohexital sodium for Injection, USP 2.5g Technical Specification:

Product Name:Methohexital sodium for Injection, USP
Brand Name:Generic
Strength:500mg, 2.5g
Dosage Form:Lyophilized
Dry Powder Injection (Sterile) *Preservative Free
Packing:1 Vial
Route of Administration:For IV use only
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier
Therapeutic use:General Anesthetics
Indication: Methohexital, a barbiturate, is used for the induction of anesthesia prior to the use of other general anesthetic agents and for induction of anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli.
Storage:Store between 20° to 25°C.

GENERIC NAME OF MEDICINAL PRODUCT:

  • Methohexital sodium for Injection, USP (2.5g)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Methohexital sodium for Injection, USP (2.5g)
    Composition:
    Each vial contains:
    Methohexital sodium…………..2.5g
    Anhydrous Sodium Carbonate………….150mg

THERAPEUTIC INDICATIONS:

Methohexital, a barbiturate, is used for the induction of anesthesia prior to the use of other general anesthetic agents and for induction of anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli.

DIRECTION OF USE:

Only use bacteriostatic-free diluents.

CAUTION & WARNING:

CAUTION: Not to be used if the reconstituted solution contains visible particulate matter.

See full prescribing information for additional storage, dosage, route of administration & dilution instruction.

Do not administer without reading directions in the full prescribing information.

FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE

WARNING: Not to be sold by retail without the prescription of a Registered Medical Practitioner only.

Contains sufficient material for several average administrations.

STORAGE & DOSAGE:

Storage: Store between 20° to 25°C.

Keep all medicines out of reach of children.

Dosage: As directed by the Physician.